Entecavir
- Product NDC
- 62227-101
- 11-digit product format
- 622270101
- Labeler code
- 62227
- Product ID
- 62227-101_9f4c7e78-9c8c-5330-e053-2a95a90aa6af
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Entecavir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- BrightGene Bio-Medical Technology Co., Ltd.
- Application
- ANDA212126
- Marketing category
- ANDA
- Marketing start
- 2019-03-08
- Marketing end
- 0000-00-00
- Substance
- ENTECAVIR
- Active strength
- 1 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62227-101-01 | 62227010101 | 30 TABLET in 1 BOTTLE, PLASTIC (62227-101-01) | 30 tablet | 2019-03-08 | 0000-00-00 | No | No | Current |
| 62227-101-02 | 62227010102 | 90 TABLET in 1 BOTTLE, PLASTIC (62227-101-02) | 90 tablet | 2019-03-08 | 0000-00-00 | No | No | Current |
| 62227-101-03 | 62227010103 | 3000 TABLET in 1 BOTTLE, PLASTIC (62227-101-03) | 3000 tablet | 2019-03-08 | 0000-00-00 | No | No | Current |